TAS-102
Has anyone had the drug TAS- 102 or know much about it ?
Comments
-
TAS-102
Hi,
The FDA will make a final approval decision on TAS-102 by December 19, 2015.
Study results:
For patients treated with TAS-102, the median overall survival was 7.1 months compared with 5.3 months with placebo (HR = 0.68; P <.0001). The median PFS in the TAS-102 arm was 2 months versus 1.7 months with placebo - See more at: http://www.onclive.com/web-exclusives/FDA-Accepts-NDA-for-TAS-102-in-mCRC#sthash.k85yXXP2.dpuf
Take a look at this link for a comprehensive description:
http://www.onclive.com/web-exclusives/FDA-Accepts-NDA-for-TAS-102-in-mCRC
For patients treated with TAS-102, the median OS was 7.1 months compared with 5.3 months with placebo (HR = 0.68; P <.0001). The median PFS in the TAS-102 arm was 2 months versus 1.7 months with placebo - See more at: http://www.onclive.com/web-exclusives/FDA-Accepts-NDA-for-TAS-102-in-mCRC#sthash.k85yXXP2.dpufFor patients treated with TAS-102, the median OS was 7.1 months compared with 5.3 months with placebo (HR = 0.68; P <.0001). The median PFS in the TAS-102 arm was 2 months versus 1.7 months with placebo - See more at: http://www.onclive.com/web-exclusives/FDA-Accepts-NDA-for-TAS-102-in-mCRC#sthash.k85yXXP2.dpufFor patients treated with TAS-102, the median OS was 7.1 months compared with 5.3 months with placebo (HR = 0.68; P <.0001). The median PFS in the TAS-102 arm was 2 months versus 1.7 months with placebo - See more at: http://www.onclive.com/web-exclusives/FDA-Accepts-NDA-for-TAS-102-in-mCRC#sthash.k85yXXP2.dpuf0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.8K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 397 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 671 Leukemia
- 792 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 237 Multiple Myeloma
- 7.1K Ovarian Cancer
- 61 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 539 Sarcoma
- 730 Skin Cancer
- 653 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards